Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
12.29
-0.08 (-0.65%)
Feb 4, 2026, 1:14 PM CST
Jiangsu Yahong Meditech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 919.2 | 628.2 | 1,738 | 1,035 | 2,613 | 279.55 |
Short-Term Investments | - | 150.54 | 14.54 | - | - | - |
Trading Asset Securities | 766.75 | 657.21 | 594.31 | 1,703 | 369.77 | 519.13 |
Cash & Short-Term Investments | 1,686 | 1,436 | 2,347 | 2,738 | 2,983 | 798.68 |
Cash Growth | 10.97% | -38.82% | -14.29% | -8.20% | 273.49% | 1320.08% |
Accounts Receivable | 90.04 | 59.9 | 8.68 | 0.02 | 0 | - |
Other Receivables | 13.45 | 11.63 | 5.9 | 3.04 | 2.07 | 0.47 |
Receivables | 103.5 | 71.53 | 14.57 | 3.06 | 2.08 | 0.47 |
Inventory | 11.74 | 5.84 | 1.61 | 2.79 | 3.81 | 4.21 |
Other Current Assets | 30.69 | 17.63 | 12.2 | 15.93 | 19.79 | 13.66 |
Total Current Assets | 1,832 | 1,531 | 2,375 | 2,760 | 3,009 | 817.01 |
Property, Plant & Equipment | 72.24 | 85.45 | 88.5 | 36.8 | 26.88 | 7.31 |
Long-Term Investments | 114.16 | 474.22 | 26.41 | 15.34 | - | - |
Other Intangible Assets | 78.67 | 53.98 | 61.39 | 21.79 | 22.13 | 0.26 |
Long-Term Deferred Tax Assets | 2.35 | 2.09 | 1.26 | 0.25 | - | - |
Long-Term Deferred Charges | 4.24 | 5.96 | 9.86 | 12.13 | 7.79 | 6.46 |
Other Long-Term Assets | 45.15 | 70.35 | 69.4 | 27.64 | 33.43 | 12.65 |
Total Assets | 2,149 | 2,223 | 2,632 | 2,874 | 3,099 | 843.68 |
Accounts Payable | 28.58 | 47.26 | 59.22 | 43.65 | 33.57 | 24.65 |
Accrued Expenses | 25.11 | 55.32 | 38.42 | 24.64 | 32.92 | 11.46 |
Short-Term Debt | 260.99 | 66.25 | 73.4 | - | - | - |
Current Portion of Leases | 16.12 | 14.34 | 10.29 | 7.37 | 5.66 | - |
Current Income Taxes Payable | 6.27 | 0.31 | 0.34 | 1.52 | - | - |
Current Unearned Revenue | - | 0.31 | - | - | - | - |
Other Current Liabilities | 30.23 | 13.28 | 3.67 | 3.48 | 1.74 | 1.07 |
Total Current Liabilities | 367.3 | 197.06 | 185.35 | 80.66 | 73.89 | 37.18 |
Long-Term Leases | 40.25 | 49.95 | 50.77 | 11.31 | 11.76 | - |
Long-Term Unearned Revenue | 4.94 | 5.61 | 6.39 | 11 | 0.32 | - |
Long-Term Deferred Tax Liabilities | - | - | - | 0 | - | - |
Total Liabilities | 412.49 | 252.62 | 242.5 | 102.98 | 85.98 | 37.18 |
Common Stock | 571.17 | 570 | 570 | 570 | 570 | 460 |
Additional Paid-In Capital | 2,906 | 2,884 | 2,863 | 2,848 | 2,841 | 509.47 |
Retained Earnings | -1,678 | -1,429 | -1,045 | -644.27 | -397.92 | -162.97 |
Treasury Stock | -50.06 | -50.06 | - | - | - | - |
Comprehensive Income & Other | -5.28 | -5.54 | -0.38 | -2.44 | - | - |
Total Common Equity | 1,745 | 1,969 | 2,388 | 2,771 | 3,013 | 806.5 |
Minority Interest | -8.3 | 0.97 | 1.8 | - | - | - |
Shareholders' Equity | 1,736 | 1,970 | 2,390 | 2,771 | 3,013 | 806.5 |
Total Liabilities & Equity | 2,149 | 2,223 | 2,632 | 2,874 | 3,099 | 843.68 |
Total Debt | 317.36 | 130.54 | 134.46 | 18.69 | 17.42 | - |
Net Cash (Debt) | 1,369 | 1,305 | 2,213 | 2,720 | 2,966 | 798.68 |
Net Cash Growth | -1.32% | -41.00% | -18.64% | -8.29% | 271.31% | 1884.46% |
Net Cash Per Share | 2.42 | 2.21 | 3.70 | 4.74 | 6.44 | 1.74 |
Filing Date Shares Outstanding | 562.5 | 561.33 | 570 | 570 | 570 | 460 |
Total Common Shares Outstanding | 562.5 | 561.33 | 570 | 570 | 570 | 460 |
Working Capital | 1,465 | 1,334 | 2,190 | 2,679 | 2,935 | 779.83 |
Book Value Per Share | 3.10 | 3.51 | 4.19 | 4.86 | 5.29 | 1.75 |
Tangible Book Value | 1,666 | 1,915 | 2,327 | 2,749 | 2,991 | 806.24 |
Tangible Book Value Per Share | 2.96 | 3.41 | 4.08 | 4.82 | 5.25 | 1.75 |
Buildings | - | - | - | - | - | 8.86 |
Machinery | - | 49.56 | 46.55 | 27.8 | 15.67 | 1.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.